Alison Gerlach

Alison Gerlach has an extensive work experience in the healthcare industry, with a focus on marketing and professional education. Alison is currently serving as the Head of Marketing at LivaNova, where they are responsible for strategic downstream marketing planning and activation, as well as the creation of education programs for healthcare professionals. Prior to this role, they were the Director of Professional Education at LivaNova, where they developed and executed a professional education strategy and led a team of specialists and consultants.

Before joining LivaNova, Alison worked at CardiacAssist, Inc. (now a part of LivaNova) as the Director of Marketing for Advanced Circulatory Support, overseeing all marketing functions and activities. Alison also held the position of Senior Marketing Manager at the same company, where they facilitated the launch of new product lines and implemented marketing excellence programs.

Earlier in their career, Alison worked at Bayer HealthCare as a Global Product Manager, leading the commercialization of a contrast injector project. Alison also served as a Global Product Marketing Manager at Medrad, where they played a key role in launching contrast injectors in multiple regions.

Alison's work experience also includes roles such as Corporate Accounts Manager and Global Customer Support Trainer at Medrad, where they managed relationships with major OEM customers and developed training programs for customer support representatives.

Overall, Alison Gerlach has a strong background in healthcare marketing, product commercialization, and professional education, with a focus on driving growth and ensuring successful product launches.

Alison Gerlach holds a Chief Marketing Officer Certification from Kellogg Executive Education (2022-2023). Alison obtained their Master of Business Administration (MBA) in International Business from Point Park University (2009-2011). Alison Gerlach also holds a Bachelor of Arts (B.A.) in Literature from Penn State University (1997-2001).